
The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.
Taiwan's Tri-Service General Hospital developed an AI-powered system to predict drug responses in autoimmune disease patients, reducing trial periods from months to 14 days with 90% accuracy. Combined with hydrogen molecule therapy, this approach has improved patient outcomes, reduced steroid dependence, and advanced precision medicine.[AI generated]



























